Kathy Y. Yi
2018
In 2018, Kathy Y. Yi earned a total compensation of $1.3M as Former Executive Vice President and Chief Financial Officer at Sangamo Biosciences, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $155,861 |
|---|---|
| Option Awards | $554,884 |
| Salary | $404,833 |
| Stock Awards | $145,363 |
| Other | $5,639 |
| Total | $1,266,580 |
Yi received $554.9K in option awards, accounting for 44% of the total pay in 2018.
Yi also received $155.9K in non-equity incentive plan, $404.8K in salary, $145.4K in stock awards and $5.6K in other compensation.
Rankings
In 2018, Kathy Y. Yi's compensation ranked 8,012th out of 14,244 executives tracked by ExecPay. In other words, Yi earned more than 43.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,012 out of 14,244 | 44th |
Division Manufacturing | 3,151 out of 5,758 | 45th |
Major group Chemicals And Allied Products | 1,173 out of 2,119 | 45th |
Industry group Drugs | 985 out of 1,808 | 46th |
Industry Biological Products, Except Diagnostic Substances | 188 out of 339 | 45th |
Source: SEC filing on April 1, 2020.
Yi's colleagues
We found two more compensation records of executives who worked with Kathy Y. Yi at Sangamo Biosciences in 2018.